Radioprotective effect of epicatechin in cultured human fibroblasts and zebrafish

Journal of Radiation Research

Volumn 55, Issue 1, 2014, Pages 32-40

  Shin, Hyang Ae ^a   Shin, Yoo Seob ^b   Kang, Sung Un ^b   Kim, Jang Hee ^b   Oh, Young Taek ^b   Park, Keun Hyung ^b   Lee, Bum Hei ^b   Kim, Chul Ho ^b  

^a National Health Insurance Corporation   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

epicatechin; fibroblast; radiation; radioprotection; zebrafish

Indexed keywords

CELL DEATH; CELL MEMBRANES; CELL SIGNALING; FIBROBLASTS; FLAVONOIDS; MITOCHONDRIA; RADIATION; RADIOTHERAPY;

CELL DAMAGE; CELLULAR DAMAGE; EPICATECHIN; FIBROBLAST; HUMAN FIBROBLAST; RADIATION-INDUCED; RADIOPROTECTION; REACTIVE OXYGEN SPECIES; WOUND HEALING; ZEBRAFISH;

CELL CULTURE;

CATECHIN; RADIOPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL; ANIMAL EMBRYO; APOPTOSIS; CELL CULTURE; CELL MOTION; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; EMBRYOLOGY; FIBROBLAST; HUMAN; METABOLISM; PHYSIOLOGY; RADIATION RESPONSE; ZEBRA FISH;

ANIMALS; APOPTOSIS; CATECHIN; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; EMBRYO, NONMAMMALIAN; FIBROBLASTS; HUMANS; RADIATION-PROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; ZEBRAFISH;

EID: 84892731294     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt085     Document Type: Article

References (39)

1. Sankaranarayanan R, Masuyer E, Swaminathan R et al. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 1998;18:4779-86.
2. Pignon JP, Bourhis J, Domenge C et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355: 949-55.
3. Nutting CM, Morden JP, Harrington KJ et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-36.
4. Al-Mamgani A, Van Rooij P, Tans L et al. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional con-formal radiotherapy for oropharyngeal cancer: a matched-pair analysis. Technol Cancer Res Treat 2013;12:123-30.
5. Tribius S, Bergelt C. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev 2011;37:511-9.
6. Zlobinskaya O, Girst S, Greubel C et al. Reduced side effects by proton microchannel radiotherapy: study in a human skin model. Radiat Environ Biophys 2013;52:123-33. doi:10.1007/s00411-012-0450-9.
7. Stone HB, Moulder JE, Coleman CN et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res 2004;162:711-28.
8. Citrin D, Cotrim AP, Hyodo F et al. Radioprotectors and miti-gators of radiation-induced normal tissue injury. Oncologist 2010;15:360-71.
9. Rastogi L, Feroz S, Pandey BN et al. Protection against radiation-induced oxidative damage by an ethanolic extract of Nigella sativa L. Int J Radiat Biol 2010;86:719-31.
10. Koukourakis MI. Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Br J Radiol 2012;85:313-30.
11. Erba D, Riso P, Bordoni A et al. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem 2005;16:144-9.
12. Edwards-Jones V, Buck R, Shawcross SG et al. The effect of essential oils on methicillin-resistant Staphylococcus aureus using a dressing model. Burns 2004;30:772-7.
13. Yamaguchi K, Honda M, Ikigai H et al. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res 2002;53:19-34.
14. Scott BC, Butler J, Halliwell B et al. Evaluation of the antioxi-dant actions of ferulic acid and catechins. Free Radic Res Commun 1993;19:241-53.
15. Zhu A, Wang X, Guo Z. Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent). Nucl Med Biol 2001;28:735-40.
16. Apostolides Z, Weisburger JH. Screening of tea clones for inhibition of PhIP mutagenicity. Mutat Res 1995;326:219-25.
17. Nakagawa T, Yokozawa T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol 2002;40: 1745-50.
18. Kim CH, Kang SU, Pyun J et al. Epicatechin protects auditory cells against cisplatin-induced death. Apoptosis 2008;13: 1184-94.
19. Nair CK, Salvi VP. Protection of DNA from gamma-radiation induced strand breaks by Epicatechin. Mutat Res 2008;650: 48-54.
20. Pyun JH, Kang SU, Hwang HS et al. Epicatechin inhibits radiation-induced auditory cell death by suppression of reactive oxygen species generation. Neuroscience 2011;199:410-20.
21. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007;2:329-33.
22. Bourhis J, Lapeyre M, Tortochaux J et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 2006;24:2873-8.
23. Bonner JA, Harari PM, Giralt J et al. Radiotherapy plus cetuxi-mab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78.
24. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003;189:1-20.
25. Goel HC, Prasad J, Singh S et al. Radioprotection by a herbal preparation of Hippophae rhamnoides, RH-3, against whole body lethal irradiation in mice. Phytomedicine 2002;9:15-25.
26. Arora R, Gupta D, Chawla R et al. Radioprotection by plant products: present status and future prospects. Phytother Res 2005;19:1-22.
27. Sandhya T, Lathika KM, Pandey BN et al. Protection against radiation oxidative damage in mice by Triphala. Mutat Res 2006;609:17-25.
28. Pandey BN, Kumar A, Tiwari P et al. Radiobiological basis in management of accidental radiation exposure. Int J Radiat Biol 2010;86:613-35.
29. Lee JS, Kang SU, Hwang HS et al. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. Toxicol Lett 2010;199:308-16.
30. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012;18: 1028-40.
31. Hinz B, Phan SH, Thannickal VJ et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012;180:1340-55.
32. Cheng AG, Cunningham LL, Rubel EW. Mechanisms of hair cell death and protection. Curr Opin Otolaryngol Head Neck Surg 2005;13:343-8.
33. Devarajan P, Savoca M, Castaneda MP et al. Cisplatin-induced apoptosis in auditory cells: role of death receptor and mito-chondrial pathways. Hear Res 2002;174:45-54.
34. Dent P, Yacoub A, Fisher PB et al. MAPK pathways in radiation responses. Oncogene 2003;22:5885-96.
35. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007;81:519-33.
36. Bu-Abbas A, Clifford MN, Walker R et al. Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea. Carcinogenesis 1994;15:2575-9.
37. Shimoi K, Nakamura Y, Tomita I et al. (1986) The pyrogallol related compounds reduce UV-induced mutations in Escherichia coli B/r WP2. Mutat Res 1986;173:239-44.
38. Terao J, Piskula M, Yao Q. Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys 1994;308: 278-84.
39. Lawenda BD, Smith DE, Xu L et al. Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodi-fying response on tumors in vivo? A pilot study with murine breast carcinoma. J Soc Integr Oncol 2007;5:11-7.